Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Psychiatry
•
General Outpatient Psychiatry
•
Neuromodulation
•
Ketamine
What criteria do you use when deciding whether to start esketamine treatment for patients with treatment resistant MDD who are concomitant CNS depressants?
Related Questions
How do you approach tapering electroconvulsive therapy after an acute treatment course leading to successful resolution of symptoms for treatment-resistant depression?
How do you determine the treatment course of esketamine or IV ketamine when used for treatment-resistant major depressive disorder?
How do you manage lamotrigine or lithium induced acne?
What types of cardiac conduction abnormalities would lead you to avoid using tricyclic antidepressants?
What are your perspectives on using GLP-1 agonists as a primary or adjunctive treatment in psychiatric care?
When do you attribute tremors to lamotrigine?
In addition to a therapist, what are your favorite resources for tackling perfectionism?
How do you support recovery in patients with MDD and AUD experiencing anhedonia and social isolation after losing alcohol-based social networks?
How do you approach anxiety management for patients who have been on long-term (years or more) daily benzodiazepines?
Do you routinely prescribe an anticholinergic agent for EPS prophylaxis when starting or continuing antipsychotics or do you prefer to use it only as needed (prn) if/when symptoms develop?
